Profile picture

Doctor Luisa Pinheiro

Unidade Local de Saude do Alto Ave, Guimaraes (Portugal)
Membership: EACVI Member
Follow
Logo ESC

Contributor content

Integrating echocardiographic parameters into prognostic assessment of wild-type transthyretin amyloid cardiomyopathy
Presentation
Integrating echocardiographic parameters into prognostic assessment of wild-type transthyretin amyloid cardiomyopathy
Uncovering predictors of atrial fibrillation in wild-type transthyretin amyloid cardiomyopathy
Presentation
Uncovering predictors of atrial fibrillation in wild-type transthyretin amyloid cardiomyopathy
Predicting atrial fibrillation in cardiac amyloidosis: the role of left atrial deformation
Presentation
Predicting atrial fibrillation in cardiac amyloidosis: the role of left atrial deformation
A matter of time: cardiac aneurysm and recurrent thromboembolic events
Presentation
A matter of time: cardiac aneurysm and recurrent thromboembolic events
Identifying predictors of non-response to cardiac resynchronization therapy in heart failure patients
Presentation
Identifying predictors of non-response to cardiac resynchronization therapy in heart failure patients
From reduced to normal left ventricular ejection fraction: what makes a super-responder to CRT?
Presentation
From reduced to normal left ventricular ejection fraction: what makes a super-responder to CRT?
Implantable loop recorder monitoring in cardiomyopathies: unveiling clinically relevant arrhythmias
Presentation
Implantable loop recorder monitoring in cardiomyopathies: unveiling clinically relevant arrhythmias
Comparative analysis of clinical adverse outcomes in cardiac resynchronization therapy: transvenous lead vs epicardial lead
Presentation
Comparative analysis of clinical adverse outcomes in cardiac resynchronization therapy: transvenous lead vs epicardial lead
Improvement of functional mitral regurgitation following cardiac resynchronization therapy: predictors and clinical outcomes
Presentation
Improvement of functional mitral regurgitation following cardiac resynchronization therapy: predictors and clinical outcomes
Therapeutic value of spironolactone in wild-type transthyretin amyloid cardiomyopathy
Presentation
Therapeutic value of spironolactone in wild-type transthyretin amyloid cardiomyopathy

ESC 365 is supported by